A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors

A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors

Bibliographic Details
Main Authors: Connor, Joseph P, Cristea, Mihaela C, Lewis, Nancy L, Lewis, Lionel D, Komarnitsky, Philip B, Mattiacci, Maria R, Felder, Mildred, Stewart, Sarah, Harter, Josephine, Henslee-Downey, Jean, Kramer, Daniel, Neugebauer, Roland, Stupp, Roger
Format: Online
Language:English
Published: BioMed Central 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600662/
id pubmed-3600662
recordtype oai_dc
spelling pubmed-36006622013-03-19 A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors Connor, Joseph P Cristea, Mihaela C Lewis, Nancy L Lewis, Lionel D Komarnitsky, Philip B Mattiacci, Maria R Felder, Mildred Stewart, Sarah Harter, Josephine Henslee-Downey, Jean Kramer, Daniel Neugebauer, Roland Stupp, Roger Research Article BioMed Central 2013-01-15 /pmc/articles/PMC3600662/ /pubmed/23320927 http://dx.doi.org/10.1186/1471-2407-13-20 Text en Copyright ©2013 Connor et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Connor, Joseph P
Cristea, Mihaela C
Lewis, Nancy L
Lewis, Lionel D
Komarnitsky, Philip B
Mattiacci, Maria R
Felder, Mildred
Stewart, Sarah
Harter, Josephine
Henslee-Downey, Jean
Kramer, Daniel
Neugebauer, Roland
Stupp, Roger
spellingShingle Connor, Joseph P
Cristea, Mihaela C
Lewis, Nancy L
Lewis, Lionel D
Komarnitsky, Philip B
Mattiacci, Maria R
Felder, Mildred
Stewart, Sarah
Harter, Josephine
Henslee-Downey, Jean
Kramer, Daniel
Neugebauer, Roland
Stupp, Roger
A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors
author_facet Connor, Joseph P
Cristea, Mihaela C
Lewis, Nancy L
Lewis, Lionel D
Komarnitsky, Philip B
Mattiacci, Maria R
Felder, Mildred
Stewart, Sarah
Harter, Josephine
Henslee-Downey, Jean
Kramer, Daniel
Neugebauer, Roland
Stupp, Roger
author_sort Connor, Joseph P
title A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors
title_short A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors
title_full A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors
title_fullStr A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors
title_full_unstemmed A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors
title_sort phase 1b study of humanized ks-interleukin-2 (huks-il2) immunocytokine with cyclophosphamide in patients with epcam-positive advanced solid tumors
description
publisher BioMed Central
publishDate 2013
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600662/
_version_ 1611963353320652800

Similar Items